The value of anti-calretinin antibody in the differential diagnosis of normal and reactive mesothelia versus metastatic tumors in effusion cytology.
In effusion cytology the distinction of reactive mesothelia from metastatic carcinoma cells may be a diagnostic challenge. Immunocytochemistry using antibodies suitable to detect epithelial cells must be considered carefully due to limited sensitivity and specificity of these antibodies. Efficient results in histological differential diagnosis of malignant mesothelioma versus lung-adenocarcinoma applying a novel antiserum against the calcium binding protein calretinin inspirated us to investigate the value of anti-calretinin antibody in effusion cytology combined with an epithelial marker. Cytoslides prepared by cytocentrifugation from 42 malignant and 65 reactive effusion specimens were immunostained using antibodies against calretinin and the epithelial marker Ber-EP4. Positive immunoreaction for calretinin in normal and reactive mesothelial cells was noted in 93% of the cases, whereas immunoreaction for calretinin was completely negative in the metastatic cells in 95% of the malignant effusions. Metastatic carcinoma cells were detected with anti-Ber-EP4 in 83% of malignant effusions. Non-specific positive reactions for Ber-EP4 in single mesothelial cells were observed in 16% of all cases and, moreover, frequently with macrophages or neutrophilic granulocytes. Our results demonstrate high sensitivity and specificity of anti-calretinin antibody for mesothelial cells in effusion specimens. They support its application to improve the diagnostic reliability of epithelial markers, especially because anti-calretinin antibody could be helpful in the assessment of false positive and false negative reactions of epithelial markers.
Nagel
H
H
Department of Cytopathology, Georg-August-University of Göttingen, Germany. hnagel@med.uni-goettingen.de
Hemmerlein
B
B
Ruschenburg
I
I
Hüppe
K
K
Droese
M
M
D000911:Antibodies, Monoclonal; D001201:Ascites / Q000473:pathology; D064032:Calbindin 2; D003937:Diagnosis, Differential; D004848:Epithelium / Q000473:pathology; D005260:Female; D006801:Humans; D007124:Immunoenzyme Techniques; D007074:Immunoglobulin G; D008654:Mesothelioma / Q000175:diagnosis*; D009362:Neoplasm Metastasis / Q000175:diagnosis; D018301:Neoplasms, Mesothelial / Q000175:diagnosis* / Q000556:secondary*; D010996:Pleural Effusion / Q000175:diagnosis*; D011237:Predictive Value of Tests; D064030:S100 Calcium Binding Protein G / Q000276:immunology*
D000911:Antibodies, Monoclonal; C117805:Ber-EP4 monoclonal antibody; C576764:CALB2 protein, human; D064032:Calbindin 2; D007074:Immunoglobulin G; D064030:S100 Calcium Binding Protein G